Drugs for Psoriasis 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 440)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Esomeprazole |
Approved, Investigational |
Phase 4 |
|
161796-78-7, 119141-88-7, 161973-10-0 |
9568614 4594 |
Synonyms:
( -)-Omeprazole
(-)-omeprazole
(−)-omeprazole
(-)-Omeprazole
(-)-Omeprazole magnesium
(S)-(−)-omeprazole
(S)-(-)-Omeprazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
(s)-omeprazole
(S)-omeprazole
(S)-Omeprazole
(S)-Omeprazole magnesium
119141-88-7
119141-89-8
131959-78-9
161973-10-0
172964-80-6
193469-77-1
1H-Benzimidazole, 5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-, magnesium salt, trihydrate
2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole
2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole
202742-32-3
217087-09-7
302841-07-2
320416-93-1
326602-80-6
371759-50-1
372519-57-8
376628-34-1
5-methoxy-1H-1,3-benzimidazol-2-yl (4-methoxy-3,5-dimethyl-2-pyridinyl)methyl sulfoxide
5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole
5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole, magnesium salt (2:1), trihydrate
5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole
6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole
6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
73590-58-6
95382-33-5
AC1L1IIJ
AC1L2XM7
AC1L2XMA
AC1NSJYQ
AC-401
AC-402
AGI-010
AKOS005066653
Alenia
Antra
Antra MUPS
AstraZeneca brand OF esomeprazole magnesium
Audazol
AULCER
Axagon
Belmazol
BIDD:GT0020
BIDD:GT0189
Bio-0888
BPBio1_000425
BRD-A55962179-001-04-9
BSPBio_000385
C07324
CAS-73590-58-6
CCRIS 7099
Ceprandal
CHEBI:50275
CHEBI:519601
CHEBI:7772
CHEMBL1503
CID130564
CID130565
CID4594
CID9568613
CID9568614
CID9579578
CPD000058847
D00455
D01984
D05259
D07917
D-961H
Danlox
DB00338
DB00736
Demeprazol
Desec
Dizprazol
DM-3458
Dudencer
Elgam
Emeproton
Emilok
Epirazole
Erbolin
Escz
Esofag
esomeprazol
Esomeprazol
esomeprazole
Esomeprazole
Ésoméprazole
Esomeprazole (INN)
Esomeprazole [INN:BAN]
Esomeprazole magnesium
Esomeprazole magnesium (USAN)
Esomeprazole magnesium hydrate
Esomeprazole magnesium hydrate (JAN)
Esomeprazole magnesium trihydrate
Esomeprazole potassium
Esomeprazole sodium
Esomeprazole Sodium
Esomeprazole strontium
Esomeprazole strontium anhydrous
esomeprazolum
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168/68
H 168-68
H 199/18
H168/68
H-168/68
H199/18
H-199/18
HMS1528I05
HMS1569D07
HMS2052G17
HMS2090E16
HMS2090F11
HSDB 3575
I06-0705
I06-1976
IDI1_032523
InChI=1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20
Indurgan
|
Inexium paranova
Inexium paranova (TN)
Inhibitron
Inhipump
KS-1054
Lensor
Logastric
Lomac
Losec
Losec, Omesec, Prilosec, Zegerid, Omeprazole
LS-181810
LS-185188
LS-7629
Lucen
magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
magnesium 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide trihydrate
Maybridge4_002645
Mepral
Miol
Miracid
MLS000069373
MLS001076112
MLS001165732
MLS001424148
MolPort-002-885-822
MolPort-003-666-741
MolPort-003-807-515
MolPort-003-849-702
MolPort-005-940-841
MolPort-005-943-880
Mopral
Morecon
N Bis (1H-Benzimidazole,5-methoxy-2-[(S)-[4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl]-)
NCGC00016925-01
NCGC00016925-02
NCGC00021522-03
NCGC00021522-04
NCGC00021522-05
Nexiam
Nexium
Nexium (TN)
Nexium Control
Nexium IV
Nexium, Esomeprazole magnesium
Nilsec
Nopramin
Nuclosina
O0359
O104_SIGMA
Ocid
Olexin
Olit
Omapren
Omebeta
Omebeta 20
Omed
Omegast
OMEP
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
omeprazole
Omeprazole (JAN/USP/INN)
Omeprazole [USAN:INN:BAN:JAN]
Omeprazole delayed-release
Omeprazole magnesium
Omeprazole S-form
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprazone
Omeprol
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
Ompanyt
OMZ
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick_808
Prestwick0_000493
Prestwick1_000493
Prestwick2_000493
Prestwick3_000493
Prilosec
Prilosec (TN)
Prilosec OTC
Prilosec OTC (TN)
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
S1389_Selleck
S1743_Selleck
SAM001246900
SAN-15
Sanamidol
Secrepina
SMR000058847
SMR000550477
SPBio_002306
ST51053319
STK623746
Strontium, esomeprazole
Tedec Ulceral
TL8005099
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
UNII-KG60484QX9
UNII-N3PA6559FT
UNII-R6DXU4WAY9
UPCMLD-DP075
UPCMLD-DP075:001
Victrix
Zefxon
Zegerid
Zepral
Zimor
ZINC04693574
ZINC04693575
Zoltum
|
|
2 |
|
Dapsone |
Approved, Investigational |
Phase 4 |
|
80-08-0 |
2955 |
Synonyms:
(4-sulfanilylphenyl)amine
1,1'-sulfonylbis(4-aminobenzene)
1,1'-Sulfonylbis(4-aminobenzene)
1,1'-Sulfonylbis[4-aminobenzene]
1,1'-Sulphonylbis(4-aminobenzene)
1358F
32960_FLUKA
4-(4-amino-benzenesulfonyl)-phenylamine
4-(4-amino-Benzenesulfonyl)-phenylamine
4-(4-amino-Benzenesulphonyl)-phenylamine
4-(4-aminophenyl)sulfonylaniline
4-(4-aminophenylsulfonyl)aniline
4-(4-Aminophenylsulfonyl)aniline
4-(4-aminophenylsulfonyl)benzenamine
4-(4-Aminophenylsulfonyl)benzenamine
4-(4-Aminophenylsulphonyl)aniline
4-(4-Aminophenylsulphonyl)benzenamine
4,4' Diaminophenyl sulfone
4,4' Diaminophenyl Sulfone
4,4'-dapsone
4,4'-Dapsone
4,4-Diaminodifenylsulfon
4,4-Diaminodifenylsulfon [Czech]
4,4'-diaminodiphenyl sulfone
4,4'-Diaminodiphenyl sulfone
4,4'-Diaminodiphenyl sulphone
4,4'-Diaminodiphenyl suphone
4,4'-Diaminodiphenylsulfone
4,4'-diaminophenyl sulfone
4,4'-Diaminophenyl sulfone
4,4'-sulfonylbisaniline
4,4'-Sulfonylbisaniline
4,4'-Sulfonylbisbenzamine
4,4'-Sulfonylbisbenzenamine
4,4'-Sulfonylbisbenzeneamine
4,4'-Sulfonyldianilin
4,4'-sulfonyldianiline
4,4'-Sulfonyldianiline
4,4-Sulfonyldianiline
4,4'-Sulfonyldianiline (Dapsone)
4,4'-Sulphonylbisaniline
4,4'-Sulphonylbisbenzamine
4,4'-Sulphonylbisbenzenamine
4,4'-Sulphonyldianiline
4-[(4-aminobenzene)sulfonyl]aniline
4-[(4-aminophenyl)sulfonyl]aniline
46158_FLUKA
46158_RIEDEL
4-Aminop henyl sulfone
4-aminophenyl sulfone
4-Aminophenyl sulfone
4-Aminophenyl sulphone
4-Aminophenylsulfone
80-08-0
A74807_ALDRICH
AB00051962
AB1004833
AC-10922
AC1L1EUH
AC1Q51WM
AC1Q51WN
Acedapsone
Aczone
Aczone (TN)
AI3-08087
AKOS000119322
ALBB-005917
Ambap80-08-0
Araldite Ht
Araldite HT
Araldite HT 976
Atrisone
Avlosulfon
Avlosulfone
Avlosulphone
Avsulfor
AZT + Dapsone cominbation
BIDD:GT0770
Bis(4-aminophenyl) sulfone
bis(4-aminophenyl)sulfone
Bis(4-aminophenyl)sulfone
Bis(4-aminophenyl)sulphone
Bis(p-aminophenyl) sulfone
Bis(P-aminophenyl) sulfone
Bis(P-aminophenyl) sulphone
Bis(p-aminophenyl)sulphone
BPBio1_000143
BRD-K62363391-001-05-8
BRN 0788055
BSPBio_000129
BSPBio_002129
C07666
CAS-80-08-0
CBDivE_013582
CCRIS 192
CHEBI:4325
CHEMBL1043
CID2955
CPD000059064
Croysulfone
Croysulphone
D SS
D003622
D00592
D0089
DADPS
Dapsoderm-X
Dapson
Dapsona
Dapsona [INN-Spanish]
dapsone
Dapsone
Dapsone (USP)
Dapsone [USAN:BAN]
Dapson-fatol
Dapson-Fatol
Dapsonum
Dapsonum [INN-Latin]
DB00250
DDS
DDS (pharmaceutical)
Dds, Diaphenylsulfone
DDS, diaphenylsulfone
Dds, Pharmaceutical
DDS, pharmaceutical
DDS, Pharmaceutical
Di(4-aminophenyl) sulfone
Di(4-aminophenyl)sulfone
Di(4-aminophenyl)sulphone
Di(p-aminophenyl) sulfone
Di(p-aminophenyl)sulphone
Diamino-4,4'-diphenyl sulfone
Diamino-4,4'-diphenyl sulphone
Diaminodifenilsulfona
Diaminodifenilsulfona [Spanish]
Diaminodiphenyl sulfone
Diaminodiphenyl Sulfone
Diamino-diphenyl sulphone
Diaminodiphenylsulfone
Diaphenylsulfon
|
Diaphenylsulfone
DIAPHENYLsulfone
Diaphenylsulfone (JAN)
Diaphenylsulphon
Diaphenylsulphone
DIAPHENYLsulphone
Dimitone
Diphenasone
Diphone
Disulone
DivK1c_000573
DSS
DSS (VAN)
Dubronax
Dubronaz
Dumitone
EINECS 201-248-4
Eporal
F 1358
Fatol brand OF dapsone
Fatol Brand of Dapsone
Hardener HT 976
HMS1568G11
HMS1920C14
HMS2091K04
HMS501M15
HSDB 5073
HT 976
HY 976
I01-3640
ICI
IDI1_000573
IN-201
KBio1_000573
KBio2_001368
KBio2_003936
KBio2_006504
KBio3_001349
KBioGR_000900
KBioSS_001368
LS-1790
Metabolite C
Mex-america brand OF dapsone
Mex-America Brand of Dapsone
MLS000069409
MLS001055349
MLS001076146
MolPort-001-780-172
N, N'-Diphenyl sulfondiamide
N, N'-Diphenyl Sulfondiamide
N,N'-Diphenyl sulfondiamide
NCGC00016322-01
NCGC00016322-02
NCGC00023946-03
NCGC00023946-04
NCGC00023946-05
NCGC00023946-06
NCI-C01718
NINDS_000573
Normet
Novophone
NSC 6091
NSC 6091D
NSC6091
NSC-6091
Oprea1_143052
Orsade brand OF dapsone
Orsade Brand of Dapsone
p, p'-Sulfonyldianiline
P, P'-Sulfonyldianiline
p,p'-diaminodiphenyl sulfone
p,p'-Diaminodiphenyl sulfone
P,P'-diaminodiphenyl sulfone
P,P'-Diaminodiphenyl Sulfone
p,p-Diaminodiphenyl sulphone
P,P'-diaminodiphenyl sulphone
P,P-Diaminodiphenyl Sulphone
p,p-Sulfonylbisbenzamine
P,P-Sulfonylbisbenzamine
p,p-Sulfonylbisbenzenamine
P,P-Sulfonylbisbenzenamine
p,p'-sulfonyldianiline
p,p-sulphonylbisbenzamine
p,p-Sulphonylbisbenzamine
P,P-Sulphonylbisbenzamine
p,p-sulphonylbisbenzenamine
p,p-Sulphonylbisbenzenamine
P,P-Sulphonylbisbenzenamine
p,p-Sulphonyldianiline
P,P-Sulphonyldianiline
p-aminophenyl sulfone
p-Aminophenyl sulfone
P-Aminophenyl sulfone
P-Aminophenyl Sulfone
P-Aminophenyl sulphone
Prestwick_152
Prestwick0_000035
Prestwick1_000035
Prestwick2_000035
Prestwick3_000035
Protogen
Recolip
SAM002554879
SMR000059064
SPBio_001025
SPBio_002050
Spectrum_000888
SPECTRUM1500222
Spectrum2_001133
Spectrum3_000375
Spectrum4_000310
Spectrum5_000825
STK387118
Sulfadione
Sulfanona-mae
Sulfanona-Mae
Sulfona
Sulfona-Mae
Sulfona-MAE
Sulfone ucb
Sulfone Ucb
Sulfone, 4,4'-diaminophenyl
Sulfone, 4,4'-Diaminophenyl
Sulfon-mere
Sulfon-Mere
Sulfonyldianiline
Sulphadione
Sulphon-mere
Sulphon-Mere
Sulphonyldianiline
Sumicure S
Tarimyl
TL8005401
Udolac
UNII-8W5C518302
W R 448
WLN: ZR DSWR DZ
WR 448
ZINC00006310
|
|
3 |
|
Clobetasol |
Approved, Experimental, Investigational |
Phase 4 |
|
25122-41-2, 25122-46-7 |
32798 5311051 |
Synonyms:
(11b,16b)-21-chloro-9-fluoro-11,17-Dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11beta,16beta)-21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11beta,16beta)-21-chloro-9-fluoro-11,17-Dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11β,16β)-21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
(9R,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
21-chloro-9-fluoro-11,17-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
21-chloro-9-fluoro-11β,17-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione 17-propionate
25122-41-2
AC-1775
AC1L1OG6
AC1NDRJ9
AC1NSJWK
BB_NC-1906
C22H28ClFO4
CHEBI:205919
CHEMBL1201362
CID10341542
CID32797
CID4630419
CID5311051
CID9844480
Clobecort Amex
Clobecort Amex (TN)
clobetasol
|
Clobetasol
Clobetasol (INN)
Clobetasol [INN:BAN]
Clobetasol 17 propionate
clobetasol 17-propanoate
clobetasol 17-propionate
Clobetasol 17-propionate
Clobetasol propionate
Clobetasol propionate E
Clobetasolum
Clobetasolum [INN-Latin]
Clobex
Clofenazon
Cormax
D07715
Dermovate
EINECS 246-633-8
Embeline
Embeline e
LS-174086
MolPort-005-909-335
NCGC00164580-01
OLUX
STK801976
Temovate
UNII-ADN79D536H
ZINC26892643
|
|
4 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
Aresol
Benylin-e
Breonesin
Bronchol
Ether, guaiacol glyceryl
Glycerin ether
Glycerin guaiacolate
glycero-Guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
|
Glycerylguaiacol
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
Guaifenesina
Guaifenesine
guaiphenesin
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
Humibid
Hustosil
Hytuss
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
O-Methoxyphenyl glyceryl ether
Organidin NR
P-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
|
|
5 |
|
carbamide peroxide |
Approved |
Phase 4 |
|
124-43-6 |
|
Synonyms:
Carbamide peroxide
Hydrogen peroxide carbamide
Urea dioxide
|
Urea hydrogen peroxide
Urea peroxide
|
|
6 |
|
Desoximetasone |
Approved |
Phase 4 |
|
382-67-2 |
5311067 |
Synonyms:
(11b,16a)-9-fluoro-11,21-Dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11beta,16alpha)-9-fluoro-11,21-Dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11β,16α)-9-fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
17 Desoxymethasone
17-Desoxymethasone
382-67-2
9a-fluoro-16a-Methyl-delta(1)-corticosterone
9a-fluoro-16a-Methyl-δ(1)-corticosterone
9alpha-fluoro-16alpha-methyl-delta(1)-corticosterone
9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone
9alpha-fluoro-16alpha-Methyl-Delta(1)-corticosterone
9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
9α-fluoro-16α-methyl-δ(1)-corticosterone
A-41-304
Abbott brand OF desoximetasone
AC1NSJXQ
Aventis brand OF desoximetasone
Bipharma brand OF desoximetasone
CHEBI:691037
CHEMBL1766
CID5311067
CPD000058856
D03697
DB00547
Deoxydexamethasone
Dermik brand OF desoximetasone
Desoxi
|
Desoximetason
Desoximetasona
desoximetasone
Desoximetasone
Désoximétasone
Desoximetasone (USP/INN)
Desoximetasonum
Desoxymethasone
Flubason
HMS2052C15
HOE-304
Hoechst brand OF desoximetasone
Ibaril
Medicis brand OF desoximetasone
MLS000028654
MLS001076073
MolPort-003-941-111
NCGC00023648-03
Optipharma brand OF desoximetasone
R-2113
SAM001246885
SMR000058856
Stiedex
Stiefel brand OF desoximetasone
Topicort
Topicort (TN)
Topicorte
Topisolon
ZINC04212854
|
|
7 |
|
Fluticasone |
Approved, Experimental |
Phase 4 |
|
90566-53-3 |
62924 |
Synonyms:
90566-53-3
AC1NSJZT
AC-456
BIDD:GT0819
C07815
CHEMBL1201396
CID5311101
D07981
Fluticaps
|
Fluticaps (TN)
Fluticason
Fluticasona
fluticasone
Fluticasone
Fluticasone (INN)
Fluticasonum
MolPort-006-666-449
S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate
|
|
8 |
|
Clocortolone |
Approved |
Phase 4 |
|
4828-27-7, 34097-16-0 |
5282493 5311052 |
Synonyms:
(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
4828-27-7
9-chloro-6a-fluoro-11b,21-Dihydroxy-16a-methyl-1,4-pregnadien-3,20-dione
9-chloro-6a-fluoro-16a-Methyl-1,4-pregnadiene-11b,21-diol-3,20-dione
9-chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione
9-chloro-6alpha-fluoro-11beta,21-Dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione
9-chloro-6alpha-Fluoro-11beta,21-dihydroxy-16alpha-methyl-1,4-pregnadien-3,20-dione
9-chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
9-chloro-6alpha-fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione
9-chloro-6alpha-fluoro-16alpha-Methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione
9-chloro-6alpha-Fluoro-16alpha-methyl-1,4-pregnadiene-11beta,21-diol-3,20-dione
9-chloro-6α-fluoro-11β,21-dihydroxy-16α-methyl-1,4-pregnadien-3,20-dione
9-chloro-6α-fluoro-16α-methyl-1,4-pregnadiene-11β,21-diol-3,20-dione
AC1NSJWN
|
CHEBI:59582
CID5311052
Clocortolon
Clocortolona
Clocortolone
CLOCORTOLONE
Clocortolone (INN)
Clocortolone acetate
Clocortolone pivalate
Clocortolonum
D07719
MolPort-005-943-442
ZINC21981454
|
|
9 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
|
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
|
Sodium citrate, anhydrous
Sodium citrate,anhydrous
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
10 |
|
Mannitol |
Approved, Investigational |
Phase 4 |
|
69-65-8 |
6251 453 |
Synonyms:
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
Ambap69-65-8
AR-1J3861
bmse000099
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
cpd without stereochemical designation
D-(-)-Mannitol
D00062
D008353
Diosmol
DL-Mannitol
D-mannite
D-mannitol
D-Mannitol
D-Mannitol (JP15)
Dulcite
e 421
e421
e-421
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Hexahydroxyhexane
Hexanhexol
HSDB 714
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
|
M9546_SIAL
M9647_SIAL
Manicol
manita
Manitol
Maniton S
Maniton-S
Manna sugar
Manna Sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit P
Mannite
mannitol
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol [USAN]
Mannitol 10%
Mannitol 10% In Plastic Container
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
Mannitol 15%
Mannitol 15% In Plastic Container
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
Mannitol 20%
Mannitol 20% In Plastic Container
MANNITOL 25%
Mannitol 5%
Mannitol 5% In Plastic Container
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
Mannitolum
Mannogem 2080
Marine crystal
Marine Crystal
MLS001335977
MLS001335978
MolPort-003-927-039
MTL
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Osmitrol 15% In Water
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
Osmitrol 20% In Water
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Osmitrol 5% In Water
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM no. 35
SDM No. 35
SMR000857324
Sorbitol-Mannitol
SORBITOL-MANNITOL IN PLASTIC CONTAINER
TL806434
UNII-3OWL53L36A
ZINC02041302
|
|
11 |
|
Strawberry |
Approved |
Phase 4 |
|
|
|
12 |
|
Orange |
Approved |
Phase 4 |
|
|
|
13 |
|
Artichoke |
Approved |
Phase 4 |
|
|
|
14 |
|
Sorafenib |
Approved, Investigational |
Phase 4 |
|
284461-73-0 |
216239 406563 |
Synonyms:
284461-73-0
4-(4-((((4-chloro-3-(Trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-(3-(4-chloro-3-Trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 439006
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY43-9006
BAY-43-9006
BAY-54-9085
Bio-0100
BRD-K23984367-001-01-8
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
D08524
|
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(Trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
nchembio.117-comp17
Nexavar
NSC-724772
NSC747971
sorafenib
Sorafenib
Sorafénib
Sorafenib (INN)
Sorafenib [INN]
Sorafenib N-oxide
Sorafenib tosylate
sorafenibum
Sorafenibum
STK627350
UNII-9ZOQ3TZI87
ZINC01493878
|
|
15 |
|
Abatacept |
Approved |
Phase 4 |
|
332348-12-6 |
10237 |
Synonyms:
|
16 |
|
Zinc |
Approved, Investigational |
Phase 4 |
|
7440-66-6 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
|
Mannosidase b, alpha
Neutral alpha mannosidase
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
17 |
|
Aspirin |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244 |
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoate
2-(ACETYLOXY)benzoIC ACID
2349-94-2
26914-13-6
2-Acetoxybenzenecarboxylate
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. empirin
A.S.A. Empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
acide 2-(acétyloxy)benzoïque
Acide acetylsalicylique
Acide acétylsalicylique
acido Acetilsalicilico
Acido acetilsalicilico
ácido acetilsalicílico
Acido O-acetil-benzoico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
AI3-02956
AIN
AKOS000118884
Aloxiprimum
ASA
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspirdrops
aspirin
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina
Aspirina 03
Aspirine
Aspir-Mox
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bialpirina
Bialpirinia
BIDD:GT0118
Bi-prin
BRN 0779271
Bufferin
C01405
Caprin
Cardioaspirin
Cardioaspirina
CCRIS 3243
Cemirit
CHEBI:15365
CHEMBL25
CID2244
Claradin
Clariprin
cMAP_000006
Colfarit
component of Midol
component of Synirin
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
Easprin
Easprin (TN)
ECM
Ecolen
Ecotrin
EINECS 200-064-1
Empirin
|
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EU-0100038
Extren
Globentyl
Globoid
Helicon
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
I14-7505
IDI1_000555
Idragin
Istopirin
Kapsazal
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
Levius
Lopac0_000038
Lopac-A-5376
LS-143
Magnecyl
Measurin
Medisyl
Micristin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
nchem.859-comp6
NCI60_002222
Neuronika
NINDS_000555
Novid
NSC 27223
NSC27223
NSC406186
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-accetylsalicylic acid
O-Acetoxybenzoate
o-acetoxybenzoic acid
o-Acetoxybenzoic acid
O-Acetoxybenzoic acid
O-Acetylsalicylate
O-acetylsalicylic acid
O-Acetylsalicylic acid
o-carboxyphenyl acetate
o-Carboxyphenyl acetate
O-Carboxyphenyl acetate
O-Carboxyphenyl acetic acid
Persistin
Pharmacin
Pirseal
PL-2200
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
Salacetin
Salcetogen
Saletin
Salicylate acetate
Salicylic acid acetate
Salicylic acid acetic acid
Salicylic acid, acetate
Salospir
SMR000059138
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
SP 189
SPBio_001838
Spectrum_001245
SPECTRUM1500130
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
ST075414
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII=R16CO5Y76E
UNII-R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
Xaxa
XAXA
Yasta
Zorprin
ZORprin
|
|
18 |
|
Brodalumab |
Approved, Investigational |
Phase 4 |
|
1174395-19-7 |
|
19 |
|
Metformin |
Approved |
Phase 4 |
|
657-24-9 |
14219 4091 |
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
cMAP_000016
D04966
DB00331
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMGG
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
Haurymelin
HMS2089D19
HSCI1_000295
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
|
KBioSS_002312
LA-6023
LS-43899
Melbin
metformin
Metformin
Metformin (USAN/INN)
Metformin [USAN:INN:BAN]
Metformin HCL
metformin hydrochloride
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
Sandoz Metformin
Siofor
SPBio_001928
STK011633
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
|
|
20 |
|
Ustekinumab |
Approved, Investigational |
Phase 4 |
|
815610-63-0 |
|
Synonyms:
|
21 |
|
Ixekizumab |
Approved, Investigational |
Phase 4 |
|
1143503-69-8 |
|
22 |
|
Vedolizumab |
Approved |
Phase 4 |
|
943609-66-3 |
|
23 |
|
Cyclophosphamide |
Approved, Investigational |
Phase 4 |
|
50-18-0, 6055-19-2 |
2907 |
Synonyms:
(-)-Cyclophosphamide
(+-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
Anhydrous cyclophosphamide
Anhydrous, cyclophosphamide
ASTA
Asta B 518
ASTA B518
B 518
B-518
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
BRN 0011744
BSPBio_002099
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
CID2907
Clafen
Claphene
CP
CPA
CTX
CY
Cycloblastin
Cyclophosphamid
cyclophosphamide
Cyclophosphamide
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide anhydrous
Cyclophosphamide monohydrate
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide, (+-)-Isomer
Cyclophosphamide, (R)-isomer
Cyclophosphamide, (S)-isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
|
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
DivK1c_000246
EINECS 200-015-4
Endoxan
Endoxan R
Endoxana
Endoxanal
Endoxan-Asta
Endoxane
Enduxan
EU-0100238
Genoxal
Hexadrin
HMS2090A12
HSDB 3047
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
Lopac0_000238
Lopac-C-0768
LS-1302
LS-99787
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
Monohydrate, cyclophosphamide
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI60_002097
NCI-C04900
Neosar
NINDS_000246
NSC 26271
NSC26271
NSC-26271
NSC273033
NSC273034
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra waste number U058
Rcra Waste Number U058
Revimmune
S1217_Selleck
Semdoxan
Sendoxan
Senduxan
SK 20501
SPBio_001071
Spectrum_000858
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
STK177249
STOCK2S-91217
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
|
|
24 |
|
Sotalol |
Approved |
Phase 4 |
|
3930-20-9, 959-24-0 |
5253 |
Synonyms:
.beta.-Cardone
27948-47-6
3930-20-9
4'-(1-hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulphonanilide
4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid
959-24-0 (mono-hydrochloride)
AB00514715
AC-19021
AC1L1JXU
b-Cardone
beta-Cardone
Betapace
Betapace AF
BPBio1_001069
BRD-A33168282-003-03-2
BSPBio_000971
C07309
C12H20N2O3S
CCRIS 4204
CHEMBL471
CID5253
d,l-Sotalol
D08525
Darob
Darob mite
Darob mite (TN)
DB00489
HMS2089K09
Knoll pharmaceutical brand OF sotalol
L013427
|
Lopac0_001055
LS-90249
Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)- (9CI)
MJ-1999
MolPort-002-042-381
N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide
N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide
NCGC00015919-05
NCGC00024899-02
NCGC00024899-03
Prestwick0_000966
Prestwick1_000966
Prestwick2_000966
Prestwick3_000966
SBB066409
Sorine
sotalol
Sotalol
Sotalol (INN)
Sotalol [INN:BAN]
Sotalol HCL
Sotalol hydrochloride
Sotalol monohydrochloride
Sotalol Monohydrochloride
Sotalolo
Sotalolum
Sotalolum [INN-Latin]
SPBio_002892
UNII-A6D97U294I
β-cardone
|
|
25 |
|
Tofacitinib |
Approved, Investigational |
Phase 4 |
|
477600-75-2 |
|
Synonyms:
|
26 |
|
Adalimumab |
Approved |
Phase 4 |
|
331731-18-1 |
16219006 |
Synonyms:
331731-18-1
Adalimumab
Adalimumab (genetical recombination)
Adalimumab (genetical recombination) (JAN)
Adalimumab (USAN/INN)
adalimumab-adaz
adalimumab-adbm
adalimumab-afzb
|
adalimumab-atto
adalimumab-bwwd
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
|
|
27 |
|
Certolizumab pegol |
Approved |
Phase 4 |
|
428863-50-7 |
|
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
Certolizumab pegol (genetical recombination)
|
Certolizumab pegol (genetical recombination) (JAN)
Certolizumab pegol (USAN/INN)
cimzia
D03441
|
|
28 |
|
Mercaptopurine |
Approved |
Phase 4 |
|
50-44-2 |
667490 |
Synonyms:
1,7-dihydro-6H-Purine-6-thione
1,7-Dihydro-6H-purine-6-thione
1,9-dihydro-6H-purine-6-thione
3,7-dihydropurine-6-thione
39454-94-9
3H-Purine-6-thiol
50-44-2
5759-99-9
5818-33-7
5818-60-0
6 Mercaptopurine
6 Mercaptopurine monohydrate
6 Mercaptopurine Monohydrate
6 MP
6 Thiohypoxanthine
6 Thiopurine
6112-76-1
6112-76-1 (monohydrate)
63810_FLUKA
6-Mercaptopurin
6-Mercaptopurine
6-Mercaptopurine monohydrate
6-MERCAPTOPURINE MONOHYDRATE
6-Merkaptopurin
6-Merkaptopurin [Czech]
6-MP
6-Purinethiol
6-Thiohypoxanthine
6-Thiopurine
6-Thioxopurine
7H-purine-6-thiol
7-Mercapto-1,3,4,6-tetrazaindene
9H-Purin-6-yl hydrosulfide
9H-Purine-6(1H)-thione
AC-11464
AC1LDI73
AG-670/31547064
AKOS000170222
AKOS000275858
Ambap50-44-2
BB_SC-0064
BSPBio_001981
BW 57 323H
C01756
C02380
C5H4N4S
CCRIS 2761
CHEBI:2208
CHEBI:50667
CHEMBL1425
CID667490
cMAP_000033
CPD000544948
D015122
D04931
DB01033
DivK1c_000493
EINECS 200-037-4
F3329-0452
FT-0083571
glaxo Wellcome brand OF 6 mercaptopurine
Glaxo Wellcome Brand of 6 Mercaptopurine
glaxo Wellcome brand OF 6-mercaptopurine
Glaxo Wellcome Brand of 6-Mercaptopurine
GlaxoSmithKline brand OF 6 mercaptopurine
GlaxoSmithKline Brand of 6 Mercaptopurine
GlaxoSmithKline brand OF 6-mercaptopurine
GlaxoSmithKline Brand of 6-Mercaptopurine
HMS1920L07
HMS2091B20
HMS501I15
HSDB 3235
I14-1716
IDI1_000493
Ismipur
KBio1_000493
KBio2_001401
KBio2_002363
KBio2_003969
KBio2_004931
KBio2_006537
KBio2_007499
KBio3_001481
|
KBio3_002842
KBioGR_001493
KBioGR_002363
KBioSS_001401
KBioSS_002366
Leukerin
Leukerin, 99% - Carc
Leupu rin
Leupurin
LS-141
M0063
Mercaleukim
Mercaleukin
Mercaptopurin
Mercaptopurin [German]
Mercaptopurina
Mercaptopurina [INN-Spanish]
Mercaptopurina wellcome
Mercaptopurina Wellcome
mercaptopurine
Mercaptopurine
Mercaptopurine (anhydrous)
Mercaptopurine (INN)
Mercaptopurine (VAN)
Mercaptopurine anhydrous
Mercaptopurine monohydrate
Mercaptopurine Monohydrate
Mercaptopurinum
Mercaptopurinum [INN-Latin]
Mercapurin
Merkaptopuryna
Merkaptopuryna [Polish]
Mern
MLS001066623
MLS001304020
MLS001304953
MolPort-001-783-696
MolPort-001-815-626
MolPort-003-846-751
MP
NCGC00094717-01
NCGC00094717-02
NCGC00094717-03
NCI60_041653
NCI-C04886
NCIMech_000025
NINDS_000493
NSC 755
NSC755
NSC-755
PM6
Puri nethol
Puri Nethol
Purimethol
purine antimetabolite: inhibits nucleic acid replication
Purine-6(1H)-thione
Purine-6-thiol
Purinethiol
Purinethol
Puri-nethol
Puri-Nethol
Purinethol (TN)
Purinethol, 6-mercaptopurine, 6-MP, Mercaptopurine
S1305_Selleck
SAM002589937
SMR000544948
SPBio_000219
Spectrum_000921
SPECTRUM1500387
Spectrum2_000060
Spectrum3_000491
Spectrum4_000857
Spectrum5_000950
STK727062
Thiopurine
U-4748
UNII-PKK6MUZ20G
Wellcome brand OF 6 mercaptopurine
Wellcome Brand of 6 Mercaptopurine
Wellcome brand OF 6-mercaptopurine
Wellcome Brand of 6-Mercaptopurine
WLN: T56 BM DN FN HNJ ISH
Xaluprine
|
|
29 |
|
Betamethasone |
Approved, Vet_approved |
Phase 4 |
|
378-44-9 |
9782 |
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16b-Methyl-1,4-pregnadiene-9a-fluoro-11b,17a,21-triol-3,20-dione
16β-methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9.alpha.-Fluoro-16.beta.-methylprednisolone
9a-fluoro-16b-Methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-fluoro-16beta-Methylprednisolone
9alpha-Fluoro-16beta-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-fluoro-16beta-Methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-fluoro-16b-Methylprednisolone
9-fluoro-16β-methylprednisolone
9-Fluoro-16β-methylprednisolone
9α-fluoro-16β-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
betamethasone
beta-Methasone
Betamethasone
Bétaméthasone
Betamethasone (JP15/USP/INN)
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
beta-Methasone alcohol
Betamethasone alcohol
Betamethasone Base
Betamethasone cream
Betamethasone Valearate
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
Betasolon
Betnelan
Betsolan
|
BIDD:PXR0047
b-Methasone alcohol
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
C22H29FO5
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
CHEBI:3077
CHEMBL632
CID3003
CID9782
Cidoten
CPD000339803
D00244
D1961
DB00443
Desacort-Beta
EINECS 206-825-4
Flubenisolone
HMS1569I05
Hormezon
HSDB 3015
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
Methazon
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
MLS-0310139.0001
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC39470
NSC-39470
Prestwick_703
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
β-methasone alcohol
|
|
30 |
|
Salicylic acid |
Approved, Investigational, Vet_approved |
Phase 4 |
|
69-72-7 |
338 |
Synonyms:
105910_ALDRICH
105910_SIAL
2 Hydroxybenzoic acid
2 Hydroxybenzoic Acid
247588_SIAL
27301_SIAL
2-Carboxyphenol
2-hydroxy(1-14c)benzoic acid
2-Hydroxybenzenecarboxylate
2-Hydroxybenzenecarboxylic acid
2-HYDROXYBENZOate
2-Hydroxybenzoic acid
2-HYDROXYBENZOIC ACID
69-72-7
7681-06-3
8052-31-1
84210_FLUKA
84210_SIAL
AB1002436
AC1L190M
AC1Q1HCK
AC1Q72IF
Acid, 2-hydroxybenzoic
Acid, 2-Hydroxybenzoic
Acid, o-Hydroxybenzoic
Acid, O-hydroxybenzoic
Acid, ortho-hydroxybenzoic
Acid, ortho-Hydroxybenzoic
Acid, salicylic
Acid, Salicylic
Acido o-idrossibenzoico
Acido o-idrossibenzoico [Italian]
Acido salicilico
ácido salicílico
Acido salicilico [Italian]
Acidum salicylicum
Advanced pain relief callus removers
Advanced pain relief corn removers
AI3-02407
AKOS000118979
Akurza Cream
Akurza Lotion
Alpha/Beta Hydroxy Acids (Glycolic Acid, Salicylic Acid)
ALPHA/BETA HYDROXY ACIDS (SALICYLIC ACID) (SEE ALPHA/BETA HYDROXY ACIDS)
AR-1E2203
ATA fraction 10, ammonium salt
Benzoic acid, 2-hydroxy- (9CI)
BENZOIC ACID,2-HYDROXY SALICYLIC ACID
BIDD:ER0602
bmse000252
BRN 0774890
C00805
Caswell No. 731
CCRIS 6714
CHEBI:16914
CHEMBL424
CID338
Clear away wart remover
CMC_13852
Compound w
Compound W
D00097
D020156
DB00936
DHS Sal Shampoo
DivK1c_000301
Domerine
Dr. scholl's callus removers
Dr. Scholl's callus removers
Dr. scholl's corn removers
Dr. Scholl's corn removers
Dr. scholl's wart remover kit
Dr. Scholl's wart remover kit
Duofil wart remover
Duofilm
Duoplant
DuoPlant Gel
E9A559BE-383B-4F83-BC02-3031D03D558A
EINECS 200-712-3
EPA Pesticide Chemical Code 076602
Freezone
H0206
HSDB 672
Hydrisalic Gel
I04-0192
IDI1_000301
InChI=1/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10
Ionil
Ionil plus
Ionil-Plus
|
K 537
K 557
KBio1_000301
KBio2_001428
KBio2_003996
KBio2_006564
KBioSS_001428
Keralyt
Kyselina 2-hydroxybenzoova
Kyselina 2-hydroxybenzoova [Czech]
Kyselina salicylova
Kyselina salicylova [Czech]
LS-2169
Mediplast pads
MLS000069653
MolPort-001-769-476
NCGC00159447-02
NCGC00159447-04
NINDS_000301
NSC 180
NSC180
NSC629474
o Hydroxybenzoic Acid
O Hydroxybenzoic acid
o-Carboxyphenol
O-carboxyphenol
O-Carboxyphenol
Occlusal
O-Hydroxybenzoate
o-hydroxybenzoic acid
O-hydroxybenzoic acid
O-Hydroxybenzoic acid
Oprea1_040343
ortho Hydroxybenzoic acid
ortho Hydroxybenzoic Acid
ortho-Hydroxybenzoic acid
ortho-Hydroxybenzoic Acid
Orthohydroxybenzoic acid
P&S Shampoo
phenol derivative, 7
Phenol-2-carboxylate
Phenol-2-carboxylic acid
Propa pH Peel-Off Acne Mask
Psoriacid-S-stift
Retarder SAX
Retarder W
Rutranex
S5922_SIGMA
S7401_SIGMA
S8519_SIGMA
Salex Cream
Salex Lotion
Salicyclic acid
salicylate
Salicylate
salicylic acid
Salicylic acid & Sulfur Soap
Salicylic acid (6CI,8CI)
Salicylic acid (JP15/USP)
SALICYLIC ACID (SEE ALSO ALPHA HYDROXY ACIDS)
Salicylic acid (TN)
Salicylic acid [USAN:JAN]
Salicylic acid collodion
Salicylic acid soap
SALICYLIC ACID, ACS
Salicylic acid, tech
Salicylic acid, tech.
Salicylic acid-ring-UL-14C
Saligel
Salonil
SAX
SBB052826
Sebucare
Sebulex
SGCUT00012
SMP2_000145
SMR000059163
Spectrum_000948
STK258681
Stri-dex
Stri-Dex
to_000004
trans-Ver-sal
Trans-Ver-Sal
UNII-O414PZ4LPZ
UPCMLD-DP126
UPCMLD-DP126:001
Verrugon
W398500_ALDRICH
WLN: QVR BQ
|
|
31 |
|
Capsaicin |
Approved |
Phase 4 |
|
404-86-4 |
1548943 |
Synonyms:
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide
(e)8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide
(E)-8-Methyl-N-vanillyl-6-nonenamide
(e)-8-Methyl-N-vanillyl-6-nonenamide(8CL)
(E)-Capsaicin
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
12084_FLUKA
21748_FLUKA
21748_SIGMA
21750_FLUKA
21750_SIGMA
360376_ALDRICH
360376_SIGMA
404-86-4
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)
8 Methyl N vanillyl 6 nonenamide
8 Methyl N Vanillyl 6 Nonenamide
8-Methyl-N-vanillyl-6-nonenamide
8-Methyl-N-Vanillyl-6-Nonenamide
8-Methyl-N-vanillyl-trans-6-nonenamide
912457-62-6
AC1LU7K3
AC1Q46B3
Alacan brand OF capsaicin
Alacan Brand of Capsaicin
Antiphlogistine rub a-535 capsaicin
Antiphlogistine Rub A-535 Capsaicin
Axsain
Bio-0615
BPBio1_001053
BRD-K37056290-001-01-1
BRD-K50590187-001-06-6
BRN 2816484
BSPBio_000957
BSPBio_001548
BSPBio_002917
C06866
C-1700
C18H27NO3
Capsaicin
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))
Capsaicin (in oleoresin of capsicum)
Capsaicin (JAN/USP)
Capsaicin (Natural)
Capsaicin [in oleoresin of capsicum]
Capsaicin [USAN]
Capsaicin Patch
Capsaicina
Capsaicine
CAPSAICINE
Capsicum farmaya
Capsicum Farmaya
Capsidol
Capsin
Capzasin
Carter horner brand OF capsaicin
Carter Horner Brand of Capsaicin
Caswell No. 158
CCRIS 1588
Centrum brand OF capsaicin
Centrum Brand of Capsaicin
CHEBI:3374
CHEMBL294199
CID1548943
D002211
D00250
depletes Substance P
e-Capsaicin
E-CAPSAICIN
EINECS 206-969-8
Elan brand OF capsaicin
Elan Brand of Capsaicin
EPA Pesticide Chemical Code 070701
epsilon-Capsaicin
FEMA No. 3404
Flemming brand OF capsaicin
Flemming Brand of Capsaicin
FT-0082538
Gelcen
|
HMS1361N10
HMS1570P19
HMS1791N10
HMS1921H11
HMS1989N10
HMS2089N11
HMS2092D21
HMS501B16
HSDB 954
I01-2469
IDI1_000354
IDI1_034018
Isodecenoate
Isodecenoate vanillylamide
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
Link brand OF capsaicin
Link Brand of Capsaicin
LS-2138
M1149
M2028_SIGMA
Medicis brand OF capsaicin
Medicis Brand of Capsaicin
MEGxp0_001448
MLS002154049
MolPort-001-742-263
MR3H3
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
N-[(4-hydroxy-3-methoxy-phenyl)methyl]nonanamide
NCGC00090853-01
NCGC00090853-02
NCGC00090853-03
NCGC00090853-04
NCGC00090853-06
NCGC00090853-07
NCGC00090853-08
NCGC00090853-09
nchembio.146-comp1
nchembio862-comp2
NCI-C56564
neurotoxic
NGX 4010
NGX-1998
NGX-3781
NGX4010
NGX-4010
NGX-7325
NSC 56353
NSC56353
Prestwick_204
Prestwick2_000879
Prestwick3_000879
Qutenza
S1990_Selleck
SDCCGMLS-0066678.P001
Smaller brand OF capsaicin
Smaller Brand of Capsaicin
SMP2_000337
SMR000718774
SPECTRUM1501128
Spectrum5_000538
Styptysat
Thompson brand OF capsaicin
Thompson Brand of Capsaicin
TL8002946
TQ-1018
trans-8-Methyl-N-vanillyl-6-nonenamide
Transacin
trans-Capsaicin
UNII-S07O44R1ZM
UPCMLD-DP092
UPCMLD-DP092:001
UPCMLD-DP092:002
Vinas brand OF capsaicin
Vinas Brand of Capsaicin
Zacin
ZINC01530575
Zostrix
ZOSTRIX (TN)
Zostrix HP
|
|
32 |
|
Vitamin A |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
22737-96-8, 68-26-8, 11103-57-4 |
9904001 445354 |
Synonyms:
(11-cis,13-cis)-Retinol acetate
(13cis)-Retinol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
[11,12-3H]-Retinol
11,13-Di-cis-vitamin a acetate
11103-57-4
11-cis-13-cis-Retinol acetate
11-cis-13-cis-Retinyl acetate
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
alin
All Trans Retinol
All-trans retinol
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-retinol
all-trans-Retinol
all-trans-retinyl alcohol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-vitamin A alcohol
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
Alphalin
Alphasterol
A-Mulsal
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
AR-1L3057
A-Sol
Atars
ATAV
Avibon
A-Vi-Pel
Avita
A-Vitan
Avitol
Axerol
Axerophthol
Axerophtholum
Bentavit A
beta-Retinol
BIDD:PXR0102
Biosterol
BRN 0403040
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
Chocola A
CID445354
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
Hi-A-Vita
|
HMS1921B04
HMS2092L13
HMS501I08
Homagenets Aoral
Homagenets aorl
HSDB 815
Hydrovit A
IDI1_000486
Lard Factor
LMPR01090001
LPK
LS-1578
M.V.C. 9+3
M.V.I.-12
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
Nio-A-Let
NSC 122759
NSC122759
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
retinol
Retinol
RETINOL
Retinol [INN:BAN]
Retinol solution
Retinol-(cellular-retinol-binding-protein)
Retinol, all-trans- (8CI)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
Sehkraft A
SMP2_000102
SMR000112036
Solu-A
SPECTRUM1501203
Spectrum5_000993
Spectrum5_001997
ST057232
Super A
Testavol
Testavol S
Thalasphere
trans-retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
tROL
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-a
Vi-Alpha
Vi-Dom-A
Vio-A
Vitamin A
Vitamin- A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin- A alcohol
Vitamin A alcohol (VAN)
Vitamin- A alcohol solution
Vitamin A cryst
Vitamin A1
Vitamin- A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
Wachstumsvitamin
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
ZINC03831417
Zinosan N
|
|
33 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-carboxy-3-hydroxypentane-1,5-dioic acid
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
|
Citretten
Citric acid monoglyceride
Citric acid monohydrate
Citric acid, anhydrous
Citric Acid, Anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
H3Cit
Hydrocerol a
Kyselina citronova
Monohydrate, citric acid
Suby g
Uralyt u
uro-Trainer
|
|
34 |
|
Glycine |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
56-40-6 |
750 |
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
2-Aminoacetate
2-Aminoacetic acid
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB1002628
AB-131/40217813
AC1L19XW
AC1Q28JW
AC1Q53O0
Acid, aminoacetic
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
AI3-04085
AKOS000119626
amino-Acetate
Aminoacetate
aminoacetic acid
amino-Acetic acid
Aminoacetic acid
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
Aminoazijnzuur
Aminoessigsaeure
Aminoessigsäure
Aminoethanoate
Aminoethanoic acid
Amitone
an alpha amino acid ester
AR-1A0345
AR-1A0532
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
Biomol-NT_000195
bmse000089
BPBio1_001222
C00037
Calcium salt glycine
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
Cobalt salt glycine
Copper salt glycine
Corilin
CPD-8569
D00011
DB00145
EINECS 200-272-2
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
|
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
Glicina
Glicina [INN-Spanish]
Glicoamin
gly
Gly
GLY (IUPAC abbrev)
Glycin
glycine
Glycine
Glycine (JP15/USP)
Glycine [INN]
GLYCINE 1.5% IN PLASTIC CONTAINER
Glycine carbonate (1:1), monosodium salt
Glycine carbonate (2:1), monolithium salt
Glycine carbonate (2:1), monopotassium salt
Glycine carbonate (2:1), monosodium salt
Glycine hydrochloride
Glycine hydrochloride (2:1)
Glycine iron sulphate (1:1)
Glycine phosphate
Glycine phosphate (1:1)
Glycine sulfate (3:1)
GLYCINE, ACS
Glycine, calcium salt
Glycine, calcium salt (2:1)
Glycine, cobalt salt
Glycine, copper salt
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, monoammonium salt
Glycine, monopotasssium salt
Glycine, monosodium salt
Glycine, non-medical
Glycine, sodium hydrogen carbonate
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-hydralin
H2N-CH2-COOH
Hampshire glycine
Hgly
H-Gly-OH
HSDB 495
Hydrochloride, glycine
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L001246
L-alpha-amino acids
Leimzucker
L-Glycine
LS-218
MolPort-000-871-607
Monoammonium salt glycine
Monopotasssium salt glycine
Monosodium salt glycine
NCGC00024503-01
NCGC00024503-02
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
NChemBio.2007.13-comp1
nchembio.265-comp9
nchembio.266-comp30
NSC 25936
NSC25936
P8791_SIGMA
Padil
Phosphate, glycine
polyglycine
Polyglycine II
S04-0135
Salt glycine, monoammonium
Salt glycine, monosodium
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
|
|
35 |
|
Retinol palmitate |
|
Phase 4 |
|
|
|
36 |
|
retinol |
|
Phase 4 |
|
|
|
37 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 4 |
|
|
|
38 |
|
Omega 3 Fatty Acid |
|
Phase 4 |
|
|
|
39 |
|
Chelating Agents |
|
Phase 4 |
|
|
|
40 |
|
Halobetasol |
|
Phase 4 |
|
|
|
41 |
|
Tin Fluorides |
|
Phase 4 |
|
|
|
42 |
|
Heptavalent Pneumococcal Conjugate Vaccine |
|
Phase 4 |
|
|
|
43 |
|
Chondroitin |
|
Phase 4 |
|
9007-27-6 |
53477707 |
Synonyms:
(2R,3R,4S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-Dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid
4-Deoxy-L-threo-hex-4-enopyranosyluronic acid-(1,3)-N-acetyl-D-galactosamine
Chondroitin disaccharide
|
Chondroitin-D-glucuronate
Unsaturated chondroitin disaccharide
|
|
44 |
|
Clocortolone pivalate |
|
Phase 4 |
|
|
|
45 |
|
Olive |
|
Phase 4 |
|
|
|
46 |
|
Citrate |
|
Phase 4 |
|
|
|
47 |
|
diuretics |
|
Phase 4 |
|
|
|
48 |
|
Anticoagulants |
|
Phase 4 |
|
|
|
49 |
|
Lidocaine, Prilocaine Drug Combination |
|
Phase 4 |
|
|
|
50 |
|
Pyrithione zinc |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 1686)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Phase4,Multicenter, Randomized,Double-blind,Double Dummy, Parallel Controlled Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Treatment of Chinese Patients With Moderate to Severe Psoriasis Vulgaris |
Unknown status |
NCT01443338 |
Phase 4 |
Triptergium Wilfordii;Acitretin |
2 |
The Influence of Adalimumab vs. Fumaric Acid Esters on Cardiovascular and Metabolic Risk Factors in the Therapy of Patients With Moderate to Severe Psoriasis Vulgaris |
Unknown status |
NCT01088165 |
Phase 4 |
Adalimumab treatment arm;Fumaric acid esters treatment group |
3 |
A Randomized Controlled Trial Comparing the Efficacy and Safety Profile of Oral Versus Subcutaneous Route of Methotrexate Administration in Moderate to Severe Psoriasis |
Unknown status |
NCT03408756 |
Phase 4 |
methotrexate |
4 |
An Open Label Trial to Show That Subjects With Severe Plaque-Type Psoriasis Receiving Acitretin 25 mg/Day And Stabilized On A Photochemotherapy Regimen Who Are Experiencing Retinoid-Related Adverse Events, Benefit From A Reduction In Acitretin Dose to 17.5 mg/Day, While Maintaining Comparable Efficacy Along With Improved Tolerability |
Unknown status |
NCT01228409 |
Phase 4 |
Acitretin 17.5 mg/day |
5 |
Improvement in the Quality of Life of Patients With Severe Plaque Psoriasis Treated With Systemic Methotrexate in Fixed Doses of 10mg or 25mg Orally Once Weekly: a Prospective, Randomized, Double-blind, Parallel Group Study. |
Unknown status |
NCT02248792 |
Phase 4 |
Methotrexate |
6 |
A Phase 4 Multicenter, Randomized, Placebo-controlled Study Evaluating the Effect of Apremilast on Pruritus and Quality of Life of Patients With Moderate-to-severe Scalp Psoriasis |
Unknown status |
NCT03553433 |
Phase 4 |
Apremilast 30mg;Placebo Oral Tablet |
7 |
The Difference of Circulating Endothelial-derived and Platelet-derived Microparticles in Patients With Psoriasis Successfully Treated With Stelara(Ustekinumab) |
Unknown status |
NCT02693470 |
Phase 4 |
Ustekinumab |
8 |
Proton Pump Inhibitors Use in Patients With Psoriasis |
Unknown status |
NCT02624544 |
Phase 4 |
esomeprazole;desonide |
9 |
Phase IV Study on Efficacy and Safety of the Combination Treatment Acitretin and Efalizumab in Moderate to Severe Chronic Plaque Psoriasis |
Unknown status |
NCT00707070 |
Phase 4 |
efalizumab plus placebo;efalizumab plus acitretin |
10 |
Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic: Nail Disease a Single-blind, Intrapatient Left-to-right Controlled Study. |
Unknown status |
NCT03263624 |
Phase 4 |
Tazarotene Cream 0.1% |
11 |
An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use |
Unknown status |
NCT01132235 |
Phase 4 |
|
12 |
Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis: a Randomized, Investigator-blinded Study |
Unknown status |
NCT01439425 |
Phase 4 |
|
13 |
Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After Adalimumab Therapy |
Unknown status |
NCT01237262 |
Phase 4 |
Adalimumab, etanercept, infliximab |
14 |
A Double - Blind, Placebo Controlled Crossover Study to Evaluate The Efficacy and Tolerability of Stelara ™ (Ustekinumab) in The Treatment of Scalp Psoriasis |
Unknown status |
NCT01558310 |
Phase 4 |
Ustekinumab;Placebo |
15 |
Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness |
Unknown status |
NCT00150930 |
Phase 4 |
|
16 |
Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Comparison With Tuberculin Skin Test in Patients With Psoriasis and Psoriatic Arthritis |
Unknown status |
NCT01223976 |
Phase 4 |
|
17 |
A Phase IV, Randomised, Multicentre, Double-blind, Study to Evaluate the Clinical Utility of Prospective Genetic Screening (HLA-B*1301) for Susceptibility to Dapsone Hypersensitivity Syndrome |
Unknown status |
NCT02550080 |
Phase 4 |
Dapsone |
18 |
The Effect of Vitamin A Supplementation on CD4+ T-cell Secretion in Obese Individuals |
Unknown status |
NCT01405352 |
Phase 4 |
|
19 |
A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris. |
Completed |
NCT02733874 |
Phase 4 |
Compound Clobetasol Propionate Ointment;Calcipotriol Betamethasone Ointment |
20 |
A Randomised, Double-Blind, Active-Controlled, Parallel, Multi-Center Study to Investigate the Efficacy and Safety of Daivobet® Ointment in Patients With Psoriasis Vulgaris |
Completed |
NCT00248456 |
Phase 4 |
Calcipotriol plus betamethasone dipropionate ointment |
21 |
Different Treatment Regimens of Calcipotriol Cream and Combination (Calcipotriol/Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris |
Completed |
NCT00216892 |
Phase 4 |
Calcipotriol, (calcipotriol + betamethasone) |
22 |
An Extension Study of Brodalumab in Subjects With Plaque Psoriasis (Psoriasis Vulgaris, Psoriatic Arthritis), Pustular Psoriasis (Generalized) and Psoriatic Erythroderma |
Completed |
NCT04183881 |
Phase 4 |
Brodalumab 210mg SC |
23 |
Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population |
Completed |
NCT02533973 |
Phase 4 |
Xamiol® gel;Daivonex® scalp solution |
24 |
Investigator Initiated Study for Optimal Maintenance Treatment With Calcipotriol /Betamethasone Dipropionate Gel in Korean Patients With Psoriasis Vulgaris |
Completed |
NCT02004574 |
Phase 4 |
Calcipotriol/betamethasone dipropionate gel |
25 |
A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 mo of Age) With Mild to Moderate Plaque Psoriasis |
Completed |
NCT02125279 |
Phase 4 |
Calcitriol |
26 |
A Double-blinded, Placebo-controlled Study to Evaluate the Tolerability and Efficacy of Enstilar® (Calcipotriene and Betamethasone Dipropionate) Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color |
Completed |
NCT03506477 |
Phase 4 |
Enstilar® foam;Vehicle foam |
27 |
A Phase 4 Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis |
Completed |
NCT03331835 |
Phase 4 |
Fumaric acid esters |
28 |
A Randomized Study Combining Etanercept and Short Courses of Narrow-Band UVB in Patients With Psoriasis Vulgaris |
Completed |
NCT00640393 |
Phase 4 |
Etanercept |
29 |
Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris |
Completed |
NCT01707043 |
Phase 4 |
Taclonex |
30 |
A Preliminary, Open Label, Single-arm Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy |
Completed |
NCT01761019 |
Phase 4 |
Taclonex Topical Suspension |
31 |
Formulation and Clinical Evaluation of Ethosomal and Liposomal Preparations of Anthralin in Psoriasis |
Completed |
NCT03348462 |
Phase 4 |
ethosomal preparation of anthralin;liposomal preparation of anthralin |
32 |
A Clinical Study Comparing the Efficacy of Ultravate Ointment Once Daily vs. Twice Daily in Combination With Lac-Hydrin Lotion in the Treatment of Stable Plaque Psoriasis |
Completed |
NCT00990561 |
Phase 4 |
Ultravate ointment twice daily + LacHydrin lotion twice daily;Ultravate ointment once daily + LacHydrin lotion twice daily |
33 |
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Etanercept in Treating Scalp Involvement in Subjects With Moderate to Severe Plaque Psoriasis |
Completed |
NCT00791765 |
Phase 4 |
|
34 |
Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel (Etanercept) in Psoriasis |
Completed |
NCT00332332 |
Phase 4 |
|
35 |
A Randomized, Open Label Study to Evaluate the Safety and Efficacy of Etanercept in the Treatment of Subjects With Psoriasis |
Completed |
NCT00195507 |
Phase 4 |
Etanercept |
36 |
A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe Psoriasis |
Completed |
NCT00663052 |
Phase 4 |
Etanercept;Etanercept |
37 |
Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05% |
Completed |
NCT01893567 |
Phase 4 |
Clobex Spray |
38 |
A Multicenter, Open-label, Randomized, Pilot-study to Evaluate the Efficacy and Safety of the Combination of Etanercept (ETN) and Methotrexate and of Etanercept (ETN) Alone in Patients With Plaque Psoriasis Despite Methotrexate Therapy |
Completed |
NCT00161655 |
Phase 4 |
Etanercept;Methotrexate |
39 |
A Randomized Pilot Study Evaluating the Efficacy and Safety of Etanercept in Patients With Moderate to Severe Plaque Psoriasis After Cessation of Ciclosporin Therapy |
Completed |
NCT00581555 |
Phase 4 |
Etanercept |
40 |
Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate: a Phase IV, Multicenter, Randomized, Double-blind, Controlled Trial |
Completed |
NCT02313922 |
Phase 4 |
etanercept combined with methotrexate or etanercept combined with placebo |
41 |
An Open-Label Phase 4 Study in Adult Patients With Chronic Plaque Psoriasis to Evaluate the Immune Response to Pneumococcal Vaccine in Subjects Treated With Alefacept |
Completed |
NCT00493324 |
Phase 4 |
alefacept;polyvalent pneumococcal vaccine |
42 |
Elocon vs Fluticasone in Localized Psoriasis |
Completed |
NCT00763529 |
Phase 4 |
Mometasone;Fluticasone |
43 |
Evaluating Safety in Patients With Moderate to Severe Psoriasis Treated With Etanercept |
Completed |
NCT00581165 |
Phase 4 |
Etanercept |
44 |
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis |
Completed |
NCT03573323 |
Phase 4 |
Ixekizumab;Guselkumab;Placebo |
45 |
Fase IV Clinical Trial to Evaluate Chondroitin Sulphate Efficacy and Safety in Patients With Knee Osteoarthritis and Psoriasis |
Completed |
NCT00669123 |
Phase 4 |
Chondroitin sulphate;Placebo |
46 |
Safety and Efficacy of Etanercept in Patients With Moderate to Severe Plaque Psoriasis Who Have Shown an Unsatisfactory Response to Adalimumab or Infliximab |
Completed |
NCT00967538 |
Phase 4 |
etanercept 50 mg |
47 |
An Open-Label, Multicenter Study of the Efficacy of Cloderm® Cream (Clocortolone Pivalate, 0.1%) in the Treatment of Moderate Plaque Psoriasis for 28 Days |
Completed |
NCT01714544 |
Phase 4 |
Cloderm Cream |
48 |
A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis |
Completed |
NCT00287118 |
Phase 4 |
Efalizumab |
49 |
Efficacy and Safety of Alefacept in Combination With Narrow-band UVB (nbUVB) Compared to Alefacept Alone in Subjects With Moderate to Severe Chronic Plaque Psoriasis |
Completed |
NCT00658606 |
Phase 4 |
alefacept |
50 |
An Open-Label, Study Evaluating Topicort® Topical Spray 0.25% (Desoximetasone) in Patients With Scalp Psoriasis |
Completed |
NCT02985736 |
Phase 4 |
Topicort Topical Spray |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Acitretin
alefacept
Aloe vera preparation
Anthralin
ANTHRALIN PWDR
Betamethasone
Betamethasone acetate
Betamethasone benzoate
betamethasone dipropionate
betamethasone sodium phosphate
Betamethasone valerate
BETAMETHASONE VALERATE PWDR
calcipotriene
Calcitriol
Cholecalciferol
Coal Tar
Coal tar extract
Coal tar pitch volatiles
COAL TAR,COLLOIDAL
COAL TAR,REFINED
Cod Liver Oil
|
Colloid sulfur
Cyclosporine
Etretinate
Fish Liver Oils
fluocinolone
Fluocinolone Acetonide
hydroxyurea
Methotrexate
Methotrexate Sodium
Methoxsalen
mycophenolate mofetil
mycophenolate mofetil hydrochloride
Salicylic Acid
SALICYLIC ACID PWDR
Sulfur
SULFUR PWDR
SULFUR,COLLOIDAL
tazarotene
Thioguanine
Trioxsalen
|
|